Charles River Laboratories | CRL - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.06B 20M 2026-06
Bio-Rad Laboratories USD 651M 58.9M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Cardinal Health USD 60.9B 4.73B 2026-03
Charles River Laboratories USD 1000M 4.2M 2026-06
Cigna USD 71.7B 3.18B 2026-06
Concord Medical Services Hldg CNY 259.9M 59.28M 2025-12
CVS Health USD 106.1B 5.7B 2026-06
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
Elevance Health USD 49.8B 300M 2026-06
Humana USD 40.89B 1.24B 2026-06
Illumina USD 1.16B 70M 2026-06
Incyte USD 1.67B 400M 2026-06
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.37B 220M 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
McKesson USD 105.38B 13.08B 2026-06
Merck EUR 5.43B 300M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Quest Diagnostics USD 3.04B 140M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
UnitedHealth USD 112B 300M 2026-06
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.64B 370M 2026-06
West Pharmaceutical Services USD 872.3M 27.4M 2026-06